DrugsControl Media Services
DrugsControl.org

News Detail

US FDA reduces number of samples to retain for BA/BE testing (27-03-2024)

Maryland, 27 March 2024: In a part-draft, part-final guidance issued on Tuesday, the US Food and Drug Administration (FDA) finalized its policy on the quantity of reserve samples to be retained for bioequivalence (BE) and bioavailability (BA) testing to ensure that samples are co......
View Details

Source : Regulatory Focus
US Food and Drug Administration (FDA) quantity of reserve samples bioequivalence (BE) and bioavailability (BA) testing

Related News